These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 21325866)
1. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus. Moura CG; Mangueira CL; Cruz LA; Cruz CM Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866 [TBL] [Abstract][Full Text] [Related]
2. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491 [TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009 [TBL] [Abstract][Full Text] [Related]
4. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
5. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094 [TBL] [Abstract][Full Text] [Related]
6. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534 [TBL] [Abstract][Full Text] [Related]
7. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis]. Zhang FC; Zhou B; Dong Y Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Yin Y; Wu X; Shan G; Zhang X Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943 [TBL] [Abstract][Full Text] [Related]
9. Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Potlukova E; Kralikova P Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591 [TBL] [Abstract][Full Text] [Related]
10. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738 [TBL] [Abstract][Full Text] [Related]
11. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus. Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718 [TBL] [Abstract][Full Text] [Related]
13. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
14. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989 [TBL] [Abstract][Full Text] [Related]
15. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis. Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352 [TBL] [Abstract][Full Text] [Related]
16. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis. Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies as markers for detecting concurrent disease activity in systemic lupus erythematosus. Ntali S; Karim MY Transl Res; 2010 Dec; 156(6):317-9. PubMed ID: 21078492 [No Abstract] [Full Text] [Related]
18. Anti-C1q autoantibodies in lupus nephritis. Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131 [TBL] [Abstract][Full Text] [Related]
19. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Mok CC; Ho LY; Leung HW; Wong LG Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493 [TBL] [Abstract][Full Text] [Related]
20. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis. Cai X; Yang X; Lian F; Lin X; Liang M; Li J; Chen X; Liang L; Qin S; Fu J J Rheumatol; 2010 Apr; 37(4):759-65. PubMed ID: 20194446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]